KYORIN PHARMACEUTICAL CO LTDKYORIN PHARMACEUTICAL CO LTDKYORIN PHARMACEUTICAL CO LTD

KYORIN PHARMACEUTICAL CO LTD

No trades
See on Supercharts

4569 fundamentals

KYORIN PHARMACEUTICAL CO LTD financial statements, including revenue, expenses, profit, and loss

The total revenue of 4569 for the last quarter is 26.72 B JPY, and it's 5.98% lower compared to the previous quarter. The net income of Q2 24 is 370.00 M JPY.

Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
‪0.00‬
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: JPY
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth